About Charles B. Simone
Excellence in Research
Board Certified in Radiation Oncology
Pleural and Lung Cancer
As the medical director of the Maryland Proton Treatment Center, Simone is an internationally recognized expert in the use of proton therapy for thoracic malignancies, including pleural mesothelioma.
He is heavily involved in innovative research and the development of clinical trial strategies with stereotactic body radiation therapy and radiation oncology.
Works for a High-Volume Mesothelioma Program
At Greenebaum, Simone is part of a multidisciplinary team that specializes in the diagnosis, treatment and research of pleural mesothelioma and other asbestos-related diseases.
He is a member of the Multidisciplinary Mesothelioma Tumor Board, which meets regularly to discuss and develop individualized treatment plans for each patient.
Accomplished surgeon Dr. Joseph Friedberg is head of the Mesothelioma and Thoracic Oncology Treatment Center.
It includes experts in the fields of medical oncology, thoracic surgery, pulmonary medicine, pathology and radiation oncology.
The Greenebaum Center is among the highest-volume medical facilities in the country for mesothelioma, and it shows with the results produced.
“Going to a high-volume center for oncology makes sense, but particularly for a rare cancer like mesothelioma,” Simone said.
Accomplished Researcher and Author
Simone was the co-author of a mesothelioma study that demonstrated how high-volume centers experienced shorter hospital stays, fewer complications and lower three-day readmission rates after surgery than those treated at low-volume centers.
The study, which he published in June 2018, showed 90-day mortality rates were lower and survival rates higher for those at the high-volume centers.
Simone worked previously at the University of Pennsylvania’s Abramson Cancer Center, another high-volume center.
At UPenn, he served as chief of Thoracic Oncology Services and co-director of the Penn Mesothelioma and Pleural Program.
He earned his medical degree from the University of Pennsylvania and did his resident training in radiation oncology at the National Cancer Institute, where he also completed an internship in internal medicine.
Simone uses photon and proton radiation therapy in treating patients at Greenebaum with various thoracic malignancies, including lung cancer, thymic malignancies and pleural mesothelioma.
He has published more than 150 peer-reviewed scientific articles, many of which detail the benefits of proton therapy and its place in a multimodality treatment regimen.
Much of his research is funded by the National Science Foundation, the National Institutes of Health and the Department of Defense.
He also is a member of the National Cancer Institute Thoracic Malignancies Steering Committee for malignant pleural mesothelioma.
Disclaimer: Dr. Charles B. Simone has no professional affiliation with Asbestos.com.
Share this article
Last Modified December 4, 2018
3 Cited Article Sources
University of Maryland Greenebaum Comprehensive Cancer Center. (n.d.). Meet the Mesothelioma Team.
Retrieved from: https://www.umms.org/umgccc/cancer-services/cancer-types/mesothelioma/team
University of Maryland School of Medicine. (n.d.). Charles B. Simone, MD.
Retrieved from: http://www.medschool.umaryland.edu/profiles/Simone-Charles/
- University of Maryland Greenebaum Comprehensive Cancer Center. (n.d.). Mesothelioma. Retrieved from: https://www.umms.org/umgccc/cancer-services/cancer-types/mesothelioma